Cargando…
POS-994 ANTIBODY RESPONSE TO COVID 19 VACCINATION IN CHRONIC KIDNEY DISEASE PATIENTS ON MAINTENANCE HEMODIALYSIS
Autores principales: | AKHIL, M.S., Kanakaraj, A., Ajit Kumar, S., Chennam, D., Ravichandran, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854816/ http://dx.doi.org/10.1016/j.ekir.2022.01.1038 |
Ejemplares similares
-
POS-891 HEMODIALYSIS PATIENTS WITH SEVERE COVID-19: REDUCED ANTIBODY RESPONSE
por: BEPPU, H., et al.
Publicado: (2022) -
POS-628 THE IMPACT OF OBESITY ON ADVERSE OUTCOME OF COVID-19 IN PATIENTS ON MAINTENANCE HEMODIALYSIS DUE TO DIABETIC KIDNEY DISEASE
por: Zeltyn-Abramov M., E., et al.
Publicado: (2021) -
POS-537 COVID-19 IN PATIENTS ON MAINTENANCE HEMODIALYSIS - A SINGLE CENTER EXPERIENCE
por: MAMIDI, V., et al.
Publicado: (2021) -
POS-523 EVALUATION OF PREVALENCE AND CLINICAL PRESENTATION OF COVID-19 IN PATIENTS ON MAINTENANCE HEMODIALYSIS: REPORTS FROM TWO HEMODIALYSIS CENTERS
por: HASHEMI, S., et al.
Publicado: (2021) -
P994: HEDGEHOG PATHWAY INVOLVEMENT IN MASTOCYTOSIS DEVELOPMENT
por: Polivka, L., et al.
Publicado: (2022)